Correlation of changes in inflammatory and collagen biomarkers with durable guselkumab efficacy through 2 years in participants with active psoriatic arthritis: results from a phase III randomized controlled trial.

导出 OA

翻译打印收藏纠错

第一作者： Stefan,Siebert

第一单位： School of Infection & Immunity, University of Glasgow, Sir Graeme Davies Building, 4th Floor, 120 University Place, Glasgow G12 8TA, UK.

作者： Stefan,Siebert ^[1] ; Georg,Schett ^[2] ; Siba P,Raychaudhuri ^[3] ; Monica,Guma ^[4] ; Warner,Chen ^[5] ; Sheng,Gao ^[5] ; Soumya D,Chakravarty ^[6] ; Frederic,Lavie ^[7] ; Proton,Rahman ^[8]

作者单位： School of Infection & Immunity, University of Glasgow, Sir Graeme Davies Building, 4th Floor, 120 University Place, Glasgow G12 8TA, UK. ^[1] Department of Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany. ^[2] Division of Rheumatology, Allergy and Clinical Immunology, University of California Davis, School of Medicine, Sacramento, CA, USA.;VA Northern California Health Care System, Mather, CA, USA. ^[3] Division of Rheumatology, Autoimmunity and Inflammation, Department of Medicine, University of California San Diego, La Jolla, CA, USA. ^[4] Immunology, Janssen Research & Development, LLC, Spring House, PA, USA. ^[5] Immunology, Janssen Scientific Affairs, LLC, a Johnson & Johnson Company, Horsham, PA, USA.;Division of Rheumatology, Drexel University College of Medicine, Philadelphia, PA, USA. ^[6] Immunology Global Medical Affairs, Janssen Cilag Global Medical Affairs, Issy les Moulineaux, France. ^[7] Craig L. Dobbin Genetics Research Centre, Discipline of Medicine, Division of Rheumatology, Memorial University of Newfoundland, St John's, Canada. ^[8]

关键词 IL-23/Th-17 pathway guselkumab psoriatic arthritis serum biomarkers

DOI 10.1177/1759720X241283536

PMID 39493888

发布时间 2024-11-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Therapeutic advances in musculoskeletal disease

2024年16卷

1759720X241283536页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Correlation of changes in inflammatory and collagen biomarkers with durable guselkumab efficacy through 2 years in participants with active psoriatic arthritis: results from a phase III randomized controlled trial.

Therapeutic advances in musculoskeletal disease

相似文献

Therapeutic advances in musculoskeletal disease

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Correlation of changes in inflammatory and collagen biomarkers with durable guselkumab efficacy through 2 years in participants with active psoriatic arthritis: results from a phase III randomized controlled trial.

Therapeutic advances in musculoskeletal disease

相似文献

Therapeutic advances in musculoskeletal disease

相关期刊

检索历史清除